Influence of inflammatory disorders on pharmacokinetics of lisofylline in rats: implications for studies in humans.
Świerczek A, Wyska E, Pociecha K, Baś S, Mlynarski J.
Xenobiotica · journal article · DOI 10.1080/00498254.2018.1542516 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för rac-lisofylline. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
11 träffarSelf-assembling lisofylline-fatty acid conjugate for effective treatment of diabetes mellitus.
Italiya KS, Mazumdar S, Sharma S, Chitkara D, Mahato RI, Mittal A.
Nanomedicine · research support, non-u.s. gov't; journal article · DOI 10.1016/j.nano.2018.09.014Simultaneous determination of pentoxifylline, metabolites M1 (lisofylline), M4 and M5, and caffeine in plasma and dried blood spots for pharmacokinetic studies in preterm infants and neonates.
Page-Sharp M, Strunk T, Salman S, Hibbert J, Patole SK, Manning L, Batty KT.
J Pharm Biomed Anal · journal article · DOI 10.1016/j.jpba.2017.08.030PK/PD studies on non-selective PDE inhibitors in rats using cAMP as a marker of pharmacological response.
Świerczek A, Wyska E, Baś S, Woyciechowska M, Mlynarski J.
Naunyn Schmiedebergs Arch Pharmacol · research-article; journal article · DOI 10.1007/s00210-017-1406-zPentoxifylline and its active metabolite lisofylline attenuate transforming growth factor β1-induced asthmatic bronchial fibroblast-to-myofibroblast transition.
Wójcik-Pszczoła K, Hińcza K, Wnuk D, Kądziołka D, Koczurkiewicz P, Sanak M, Madeja Z, Pękala E, Michalik M.
Acta Biochim Pol · journal article · DOI 10.18388/abp.2016_1357Physiologically based modeling of lisofylline pharmacokinetics following intravenous administration in mice.
Wyska E, Świerczek A, Pociecha K, Przejczowska-Pomierny K.
Eur J Drug Metab Pharmacokinet · research-article; journal article · DOI 10.1007/s13318-015-0260-yInterconversion and tissue distribution of pentoxifylline and lisofylline in mice.
Wyska E, Pekala E, Szymura-Oleksiak J.
Chirality · research support, non-u.s. gov't; journal article · DOI 10.1002/chir.20299Stereoselective metabolism of pentoxifylline in vitro and in vivo in humans.
Nicklasson M, Björkman S, Roth B, Jönsson M, Höglund P.
Chirality · research support, non-u.s. gov't; journal article · DOI 10.1002/chir.10121Influence of pentoxifylline, A-802710, propentofylline and A-802715 (Hoechst) on the expression of cell cycle blocks and S-phase content after irradiation damage.
Bohm L, Theron T, Binder A.
Biochim Biophys Acta · comparative study; journal article · DOI 10.1016/s0167-4889(00)00074-4Metabolism of lisofylline and pentoxifylline in human liver microsomes and cytosol.
Lillibridge JA, Kalhorn TF, Slattery JT.
Drug Metab Dispos · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1016/s0090-9556(25)08447-8Determination of oxpentifylline and a metabolite, 1-(5'-hydroxyhexyl)-3,7-dimethylxanthine, by gas--liquid chromatography using a nitrogen-selective detector.
Bryce TA, Burrows JL.
J Chromatogr · journal article · DOI 10.1016/s0378-4347(00)81138-x